Logo image of STLAP.PA

STELLANTIS NV (STLAP.PA) Stock Fundamental Analysis

EPA:STLAP - Euronext Paris - Matif - NL00150001Q9 - Common Stock - Currency: EUR

8.286  +0.01 (+0.07%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to STLAP. STLAP was compared to 32 industry peers in the Automobiles industry. STLAP has a medium profitability rating, but doesn't score so well on its financial health evaluation. STLAP has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

STLAP had positive earnings in the past year.
In the past year STLAP had a positive cash flow from operations.
STLAP had positive earnings in each of the past 5 years.
STLAP had a positive operating cash flow in each of the past 5 years.
STLAP.PA Yearly Net Income VS EBIT VS OCF VS FCFSTLAP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

1.2 Ratios

STLAP has a Return On Assets of 2.64%. This is in the better half of the industry: STLAP outperforms 65.63% of its industry peers.
STLAP's Return On Equity of 6.70% is in line compared to the rest of the industry. STLAP outperforms 50.00% of its industry peers.
STLAP's Return On Invested Capital of 3.85% is in line compared to the rest of the industry. STLAP outperforms 50.00% of its industry peers.
STLAP had an Average Return On Invested Capital over the past 3 years of 11.44%. This is significantly above the industry average of 6.40%.
The last Return On Invested Capital (3.85%) for STLAP is well below the 3 year average (11.44%), which needs to be investigated, but indicates that STLAP had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.64%
ROE 6.7%
ROIC 3.85%
ROA(3y)6.95%
ROA(5y)5.83%
ROE(3y)17.6%
ROE(5y)15.66%
ROIC(3y)11.44%
ROIC(5y)10.61%
STLAP.PA Yearly ROA, ROE, ROICSTLAP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

STLAP has a Profit Margin (3.49%) which is in line with its industry peers.
STLAP's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 3.91%, STLAP is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
STLAP's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 13.08%, STLAP is not doing good in the industry: 71.88% of the companies in the same industry are doing better.
STLAP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.91%
PM (TTM) 3.49%
GM 13.08%
OM growth 3Y-28.95%
OM growth 5Y-7.06%
PM growth 3Y-28.4%
PM growth 5Y-10.63%
GM growth 3Y-13.66%
GM growth 5Y-1.49%
STLAP.PA Yearly Profit, Operating, Gross MarginsSTLAP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

3

2. Health

2.1 Basic Checks

STLAP has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
STLAP has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, STLAP has more shares outstanding
STLAP has a worse debt/assets ratio than last year.
STLAP.PA Yearly Shares OutstandingSTLAP.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
STLAP.PA Yearly Total Debt VS Total AssetsSTLAP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

2.2 Solvency

Based on the Altman-Z score of 1.53, we must say that STLAP is in the distress zone and has some risk of bankruptcy.
STLAP has a better Altman-Z score (1.53) than 78.13% of its industry peers.
A Debt/Equity ratio of 0.31 indicates that STLAP is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.31, STLAP is doing good in the industry, outperforming 78.13% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 1.53
ROIC/WACC0.54
WACC7.07%
STLAP.PA Yearly LT Debt VS Equity VS FCFSTLAP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B

2.3 Liquidity

STLAP has a Current Ratio of 1.09. This is a normal value and indicates that STLAP is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of STLAP (1.09) is worse than 65.63% of its industry peers.
STLAP has a Quick Ratio of 1.09. This is a bad value and indicates that STLAP is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of STLAP (0.81) is worse than 71.88% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 0.81
STLAP.PA Yearly Current Assets VS Current LiabilitesSTLAP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

3

3. Growth

3.1 Past

STLAP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.56%.
The Earnings Per Share has been growing by 31.54% on average over the past years. This is a very strong growth
Looking at the last year, STLAP shows a very negative growth in Revenue. The Revenue has decreased by -17.23% in the last year.
Measured over the past years, STLAP shows a small growth in Revenue. The Revenue has been growing by 2.93% on average per year.
EPS 1Y (TTM)-16.56%
EPS 3Y32%
EPS 5Y31.54%
EPS Q2Q%-102.06%
Revenue 1Y (TTM)-17.23%
Revenue growth 3Y0.75%
Revenue growth 5Y2.93%
Sales Q2Q%-15.51%

3.2 Future

STLAP is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.15% yearly.
STLAP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.56% yearly.
EPS Next Y-62.6%
EPS Next 2Y18.5%
EPS Next 3Y27.09%
EPS Next 5Y-3.15%
Revenue Next Year25.31%
Revenue Next 2Y17.08%
Revenue Next 3Y17.94%
Revenue Next 5Y7.56%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
STLAP.PA Yearly Revenue VS EstimatesSTLAP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50B 100B 150B 200B
STLAP.PA Yearly EPS VS EstimatesSTLAP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

STLAP is valuated cheaply with a Price/Earnings ratio of 3.10.
Based on the Price/Earnings ratio, STLAP is valued cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of STLAP to the average of the S&P500 Index (27.91), we can say STLAP is valued rather cheaply.
STLAP is valuated cheaply with a Price/Forward Earnings ratio of 2.21.
Compared to the rest of the industry, the Price/Forward Earnings ratio of STLAP indicates a rather cheap valuation: STLAP is cheaper than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 37.11, STLAP is valued rather cheaply.
Industry RankSector Rank
PE 3.1
Fwd PE 2.21
STLAP.PA Price Earnings VS Forward Price EarningsSTLAP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, STLAP is valued cheaply inside the industry as 84.38% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.45
STLAP.PA Per share dataSTLAP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

STLAP's earnings are expected to grow with 27.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.1
EPS Next 2Y18.5%
EPS Next 3Y27.09%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.91%, STLAP is a good candidate for dividend investing.
STLAP's Dividend Yield is rather good when compared to the industry average which is at 5.56. STLAP pays more dividend than 87.50% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, STLAP pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.91%

5.2 History

The dividend of STLAP has a limited annual growth rate of 0.29%.
Dividend Growth(5Y)0.29%
Div Incr Years2
Div Non Decr Years2
STLAP.PA Yearly Dividends per shareSTLAP.PA Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

STLAP pays out 84.98% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of STLAP has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP84.98%
EPS Next 2Y18.5%
EPS Next 3Y27.09%
STLAP.PA Yearly Income VS Free CF VS DividendSTLAP.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B 15B
STLAP.PA Dividend Payout.STLAP.PA Dividend Payout, showing the Payout Ratio.STLAP.PA Dividend Payout.PayoutRetained Earnings

STELLANTIS NV

EPA:STLAP (7/29/2025, 7:00:00 PM)

8.286

+0.01 (+0.07%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-29 2025-07-29/bmo
Inst Owners51.73%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap24.00B
Analysts70.59
Price Target10.63 (28.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.91%
Yearly Dividend1.58
Dividend Growth(5Y)0.29%
DP84.98%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.12%
Min Revenue beat(2)-12.48%
Max Revenue beat(2)-1.77%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.91%
PT rev (3m)-10.84%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.92%
Valuation
Industry RankSector Rank
PE 3.1
Fwd PE 2.21
P/S 0.15
P/FCF N/A
P/OCF 6.09
P/B 0.29
P/tB 0.88
EV/EBITDA 1.45
EPS(TTM)2.67
EY32.22%
EPS(NY)3.75
Fwd EY45.25%
FCF(TTM)-2.46
FCFYN/A
OCF(TTM)1.36
OCFY16.43%
SpS54.17
BVpS28.21
TBVpS9.44
PEG (NY)N/A
PEG (5Y)0.1
Profitability
Industry RankSector Rank
ROA 2.64%
ROE 6.7%
ROCE 4.64%
ROIC 3.85%
ROICexc 5.4%
ROICexgc 12.72%
OM 3.91%
PM (TTM) 3.49%
GM 13.08%
FCFM N/A
ROA(3y)6.95%
ROA(5y)5.83%
ROE(3y)17.6%
ROE(5y)15.66%
ROIC(3y)11.44%
ROIC(5y)10.61%
ROICexc(3y)18.92%
ROICexc(5y)18.29%
ROICexgc(3y)62.1%
ROICexgc(5y)75.28%
ROCE(3y)13.77%
ROCE(5y)12.77%
ROICexcg growth 3Y-56.51%
ROICexcg growth 5Y-21.17%
ROICexc growth 3Y-39.69%
ROICexc growth 5Y-16.23%
OM growth 3Y-28.95%
OM growth 5Y-7.06%
PM growth 3Y-28.4%
PM growth 5Y-10.63%
GM growth 3Y-13.66%
GM growth 5Y-1.49%
F-Score3
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA 1.87
Cap/Depr 153.06%
Cap/Sales 7.05%
Interest Coverage 3.96
Cash Conversion 29.5%
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 0.81
Altman-Z 1.53
F-Score3
WACC7.07%
ROIC/WACC0.54
Cap/Depr(3y)140.23%
Cap/Depr(5y)152.03%
Cap/Sales(3y)5.82%
Cap/Sales(5y)6.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.56%
EPS 3Y32%
EPS 5Y31.54%
EPS Q2Q%-102.06%
EPS Next Y-62.6%
EPS Next 2Y18.5%
EPS Next 3Y27.09%
EPS Next 5Y-3.15%
Revenue 1Y (TTM)-17.23%
Revenue growth 3Y0.75%
Revenue growth 5Y2.93%
Sales Q2Q%-15.51%
Revenue Next Year25.31%
Revenue Next 2Y17.08%
Revenue Next 3Y17.94%
Revenue Next 5Y7.56%
EBIT growth 1Y-73.44%
EBIT growth 3Y-27.78%
EBIT growth 5Y0.11%
EBIT Next Year83.28%
EBIT Next 3Y33.4%
EBIT Next 5Y24.73%
FCF growth 1Y-158.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-82.34%
OCF growth 3Y-40.45%
OCF growth 5Y-18.8%